O-0022COMPARISON OF DOCETAXEL, FLUOROURACIL AND OXALIPLATIN OR CISPLATIN WITH OTHER MODIFIED SCHEDULES: A NEW THERAPEUTIC INDEX IN ADVANCED GASTRIC CANCER.

MLA

Pernot, Simon, et al. “O-0022Comparison of Docetaxel, Fluorouracil and Oxaliplatin or Cisplatin with Other Modified Schedules: A New Therapeutic Index in Advanced Gastric Cancer.” Annals of Oncology, vol. 24, no. suppl_4, June 2013, pp. iv19-iv20. EBSCOhost, https://doi.org/10.1093/annonc/mdt201.22.

APA

Pernot, S., Hitier, S., Rougier, P., & Van Cutsem, E. (2013). O-0022Comparison of Docetaxel, Fluorouracil and Oxaliplatin or Cisplatin with Other Modified Schedules: A New Therapeutic Index in Advanced Gastric Cancer. Annals of Oncology, 24(suppl_4), iv19-iv20. https://doi.org/10.1093/annonc/mdt201.22

Chicago

Pernot, Simon, Simon Hitier, Philippe Rougier, and Eric Van Cutsem. 2013. “O-0022Comparison of Docetaxel, Fluorouracil and Oxaliplatin or Cisplatin with Other Modified Schedules: A New Therapeutic Index in Advanced Gastric Cancer.” Annals of Oncology 24 (suppl_4): iv19-iv20. doi:10.1093/annonc/mdt201.22.